These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7829218)

  • 1. Mitoxantrone treatment of murine myeloid leukaemia sublines.
    Abubakar AA; Riches AC
    Int J Cancer; 1995 Jan; 60(2):211-5. PubMed ID: 7829218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible correlation between growth-factor sensitivity and response to mitoxantrone treatment in a murine myeloid leukaemia (SA7HD) cell line.
    Abubakar AA; Riches AC
    Acta Oncol; 1997; 36(4):421-7. PubMed ID: 9247104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of growth factor sensitivity and development of mitoxantrone resistance in transplanted recurrent SA7HD myeloid leukemia.
    Abubakar AA
    J Exp Ther Oncol; 2002; 2(6):317-24. PubMed ID: 12440222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of recurrence of mouse myeloid leukaemia after total body irradiation and bone marrow transplantation.
    Poljak-Blazi M; Popović M; Majić T
    Oncology; 1994; 51(3):282-7. PubMed ID: 8196913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of blast cell survival and proliferation to chemotherapy resistance in AML.
    Nørgaard JM; Langkjer ST; Palshof T; Clausen N; Pedersen B; Hokland P
    Br J Haematol; 1996 Jun; 93(4):888-97. PubMed ID: 8703822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation and morphological studies of primary and passaged murine radiation-induced myeloid leukaemias.
    Hepburn M; Doherty I; Briscoe C; Riches A
    Leuk Res; 1987; 11(11):1001-9. PubMed ID: 3480394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative activity of quercetin on normal bone marrow and leukaemic progenitors.
    Larocca LM; Teofili L; Leone G; Sica S; Pierelli L; Menichella G; Scambia G; Benedetti Panici P; Ricci R; Piantelli M
    Br J Haematol; 1991 Dec; 79(4):562-6. PubMed ID: 1772777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of simvastatin on the proliferation of human myeloid leukaemia cells in severe combined immunodeficient (SCID) mice.
    Clutterbuck RD; Millar BC; Powles RL; Newman A; Catovsky D; Jarman M; Millar JL
    Br J Haematol; 1998 Jul; 102(2):522-7. PubMed ID: 9695968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Fas antigen in acute myeloid leukaemia is associated with therapeutic response to chemotherapy.
    Min YH; Lee S; Lee JW; Chong SY; Hahn JS; Ko YW
    Br J Haematol; 1996 Jun; 93(4):928-30. PubMed ID: 8703827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of heat-induced haemotoxicity in a hyperthermic purging protocol of murine acute myeloid leukaemic stem cells by AcSDKP.
    Wierenga PK; Dillingh JH; Konings AW
    Br J Haematol; 1997 Dec; 99(3):692-8. PubMed ID: 9401086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the humoral regulation of granulopoiesis in leukaemic RFM mice.
    Gordon MY; Lindop PJ
    Br J Cancer; 1975 Aug; 32(2):186-92. PubMed ID: 1082341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft-versus-leukaemia activity can be predicted by natural cytotoxicity against leukaemia cells.
    Glass B; Uharek L; Zeis M; Loeffler H; Mueller-Ruchholtz W; Gassmann W
    Br J Haematol; 1996 May; 93(2):412-20. PubMed ID: 8639441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.
    Damon LE; Rugo HS; Ries CA; Linker CA
    Bone Marrow Transplant; 1996 Jan; 17(1):93-9. PubMed ID: 8673063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemia.
    Bassan R; Lerede T; Buelli M; Borleri G; Bellavita P; Rambaldi A; Barbui T
    Haematologica; 1998 May; 83(5):422-7. PubMed ID: 9658726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of murine myeloid leukaemic cells in long-term bone marrow cultures.
    Riches AC; Hepburn M; Melville J; Briscoe CV
    Bone Marrow Transplant; 1991 May; 7(5):329-33. PubMed ID: 2070141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimaeric cultures of human marrow stroma and murine leukaemia cells: evidence for abnormalities in the haemopoietic microenvironment in myeloid malignancies and other infiltrating marrow disorders.
    Dührsen U; Knieling G; Beecken W; Neumann S; Hossfeld DK
    Br J Haematol; 1995 Jul; 90(3):502-11. PubMed ID: 7646986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia.
    Damon LE; Rugo HS; Ries CA; Linker CA
    Leukemia; 1994 Apr; 8(4):535-41. PubMed ID: 8152248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of haemopoietic cells from normal and leukaemic RFM mice using an in vivo colony assay.
    Gordon MY
    Br J Cancer; 1974 Nov; 30(5):421-8. PubMed ID: 4534200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purging of acute myeloid leukaemia cells from stem cell grafts by hyperthermia: enhancement of the therapeutic index by the tetrapeptide AcSDKP and the alkyl-lysophospholipid ET-18-OCH(3).
    Wierenga PK; Setroikromo R; Vellenga E; Kampinga HH
    Br J Haematol; 2000 Dec; 111(4):1145-52. PubMed ID: 11167754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.